<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Repligen Corporation

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Repligen’s corporate headquarters are in Waltham, MA (USA), with additional administrative and manufacturing operations in Marlborough, MA; Bridgewater, NJ; Rancho Dominguez, CA; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Tony J. Hunt
    • FOUNDED
      1981
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Dynatronics Corporation

    Dynatronics Corporation

    Dynatronics is a leading medical device company committed to providing high-qualit...

    Dynatronics is a leading medical device company...

    Filing Type:    PU
    ZYPPAH, Inc.

    ZYPPAH, Inc.

    Stop the root cause of snoring by going directly after the tongue. ZYPPAH is the o...

    Stop the root cause of snoring by going directl...

    Amount Raised:    $359,340.00
    Fundraising Status:    EC
    Filing Type:    CF
    Wuxi Biologics (Cayman) Inc

    Wuxi Biologics (Cayman) Inc

    WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading glo...

    WuXi Biologics (stock code: 2269.HK), a Hong Ko...

    Filing Type:    PU
    Editas Medicine, Inc.

    Editas Medicine, Inc.

    As a leading genome editing company, Editas Medicine is focused on translating the...

    As a leading genome editing company, Editas Med...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    GlycoMimetics, Inc.

    GlycoMimetics, Inc.

    At GlycoMimetics, we are committed to helping to make a difference in the lives of...

    At GlycoMimetics, we are committed to helping t...

    Filing Type:    PU
    Market Analyst, LLC

    Market Analyst, LLC

    Market Analyst, LLC, an aggregator and reseller of market research, is based in th...

    Market Analyst, LLC, an aggregator and reseller...

    Fundraising Status:    EC
    Filing Type:    CF
    H & G Science, Inc.

    H & G Science, Inc.

    H&G Science aims to facilitate the safe and effective treatment of diseases. Our g...

    H&G Science aims to facilitate the safe and eff...

    Amount Raised:    $24,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    dna ID, Inc.

    dna ID, Inc.

    The DNA ID platform is a community marketplace for genomics research. The app allo...

    The DNA ID platform is a community marketplace ...

    Amount Raised:    $57,589.00
    Fundraising Status:    EC
    Filing Type:    CF
    CryoPort, Inc.

    CryoPort, Inc.

    Cryoport is the industry’s most trusted provider of cold chain logistics solutio...

    Cryoport is the industry’s most trusted provi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.